Lack of Clinical Trial Participants Slowing Cancer Drug Development

Lack of Clinical Trial Participants Slowing Cancer Drug Development

Hundreds of cancer drugs are in the pipeline with the potential to save millions of lives, and make even more inroads into this dreaded disease. But may of the tests are stalled, due to a lack of people willing to participate in the clinical trials which are required before a cancer drug can win approval, News Radio 1200 WOAI reports.

Dr. Anthony Tolcher, CEO of San Antonio’s Next Oncology, which conducts clinical trials on cancer drugs, says there are a number of reasons for this, but a new study shows the number one challenge is the inability of many patients to get to the locations were the trials are being conducted.

Read More